SCHEMBL26099284

SCHEMBL26099284

CNc1cc(Nc2cccn(-c3cccc(C(=O)O)c3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30393122 1.00 TYK2 (0.73) TYK2
SCHEMBL26101618 0.93 TYK2 (0.71) TYK2
SCHEMBL30392674 0.93 TYK2 (0.71) TYK2
SCHEMBL26101248 0.89 TYK2 (0.81) TYK2
SCHEMBL30393035 0.88 TYK2 (0.83) TYK2
SCHEMBL31218712 0.86 TYK2 (0.76) TYK2
SCHEMBL26101867 0.85 TYK2 (0.71) TYK2
SCHEMBL18143587 0.84 TYK2 (0.86) TYK2
SCHEMBL18143581 0.84 TYK2 (1.00) TYK2
SCHEMBL26101540 0.83 TYK2 (0.82) TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
Send feedback